Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) shares passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.51 and traded as low as $2.20. Organicell Regenerative Medicine shares last traded at $2.30, with a volume of 12,602 shares traded.
Organicell Regenerative Medicine Stock Up 8.2%
The business has a 50 day moving average price of $2.51 and a 200-day moving average price of $2.01.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a clinical?stage biotechnology company dedicated to the development and commercialization of cell and exosome?based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal?like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome?centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Further Reading
- Five stocks we like better than Organicell Regenerative Medicine
- 3 Signs You May Want to Switch Financial Advisors
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Elon Musk already made me a “wealthy man”
- The Biggest IPO Ever… Open to Everyday Folks
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
